Explore the full record of transactions filed by Williams R Sanders, Director. Officer active across 2 companies, notably AMGEN INC. In total, 9 reports have been logged. Total volume traded: €387k. The latest transaction was disclosed on 23 May 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
R. Sanders Williams is a Board Member at Amgen Inc and Laboratory Corp of America Holdings. He brings expertise in biotechnology and life sciences, influencing strategic decisions within these organizations.